News & Insights The Latest in Medtech Innovation

LifeSprout closes $28.5M Series A round

Company closed round that was led by investors from San Francisco and Baltimore, allowing the Johns Hopkins spin-out to continue clinical development of its first product. LifeSprout is a LaunchPort Resident that operates clean room, wet lab and engineering cells as part of their GMP process development efforts.

News Article
Get Started

Let’s build something together.

The LaunchPort | Copyright 2020 | All rights reserved